Regarding T1+2 cancer, the positivity of the D-marker panel was an independent risk factor for cancer recurrence, and the adjusted HR (95% CI) was 4.37 (1.05 to 18.26) after adjusting for the age, gender, and KRAS mutation (Table 4). Here, KRAS is linked to cancer.